FriskaAi Partners with Dexcom to Integrate CGM Data for Enhanced Diabetes Care

FriskaAi, an AI-powered healthcare platform, announced an agreement with Dexcom, Inc., a global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems into its platform. This collaboration marks a significant advancement in physician-directed diabetes management, leveraging continuous glucose data to support both healthcare providers and patients with actionable, personalized care programs.

FriskaAi operates as a physician-directed health and wellness platform that enables providers to implement evidence-based approaches to preventive care for diabetes and other chronic diseases. The platform's EHR-agnostic design utilizes advanced AI and mobile technology to generate personalized health insights and recommendations, creating a partnership between patients and their clinical teams in managing chronic conditions.

The integration with Dexcom CGMs represents a substantial enhancement to FriskaAi's capabilities. Dexcom's devices employ small, wearable sensors that continuously measure glucose levels and wirelessly transmit data to smart devices in real-time, eliminating the need for traditional fingerprick testing. The CGM systems also provide customizable alerts for high or low glucose levels, along with predictive alerts designed to help users maintain healthy glucose ranges.

Through the FriskaAi mobile app, data from Dexcom CGMs and other smart devices and health applications is securely integrated and continuously monitored by HIPAA-compliant, AI-powered algorithms. These sophisticated algorithms alert patients when action is recommended and generate actionable reports that clinicians can utilize at the point of care, streamlining the clinical decision-making process.

The platform's capabilities extend beyond individual patient monitoring. Aggregated health data within FriskaAi is analyzed to help physicians identify trends and risks across their patient populations, enabling more proactive and preventive care strategies. This population health management approach allows healthcare providers to intervene earlier and more effectively in managing chronic conditions.

"Impacting more than 38 million Americans, diabetes has emerged as a major public health problem, and its effective management has become a foundational element of preventive medicine," says Shaji Nair, CEO of FriskaAi. "Dexcom's pioneering CGMs are vital tools not only for diabetes management but also for informing broader care decisions. FriskaAi is excited about the potential this integration with Dexcom presents to the physicians relying on our platform for chronic disease management and the patients seeking greater control over their health and wellness."

The partnership addresses a critical need in healthcare, where diabetes management requires continuous monitoring and timely interventions. By combining Dexcom's real-time glucose monitoring technology with FriskaAi's AI-driven analytics and physician-directed platform, the integration promises to enhance chronic disease management through timely, personalized insights that empower both patients and their clinical teams to make more informed healthcare decisions.

Click here for the original news story.